Americans using unproven peptides sold by influencers and RFK Jr. allies FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking